Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Hormones and the Endocrine System > Estradiol for Sale > GMP Factory Supply Cheap Price 50-28-2 β-Estradiol bate Estradiol 50-28-2
GMP Factory Supply Cheap Price 50-28-2 β-Estradiol bate Estradiol 50-28-2 buy - large image1
GMP Factory Supply Cheap Price 50-28-2 β-Estradiol bate Estradiol 50-28-2 buy - image1

GMP Factory Supply Cheap Price 50-28-2 β-Estradiol bate Estradiol 50-28-2

GMP FDA 35 Inquiries

Unit Price: Get Latest Price
CAS No.:

50-28-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Brand:

KDG

Packaging:

1KG/BAG

Price valid (until):

2025-04-18

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptide,API,HCG,Amino Acids,Plant Extract,Vitamin

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    • Estradiol is a synthetic estrogen that may be used to treat symptoms associated with menopause or other conditions that cause low estrogen levels.
    • Estradiol is the main type of estrogen that circulates naturally in humans. In women with menstrual periods, 70 to 500mcg of natural estradiol is secreted daily, depending on the phase of the menstrual cycle. After menopause, the adrenal cortex secretes a precursor to estrogen called androstenedione, which is converted by peripheral tissues into estrone, which is the most abundant circulating estrogen in postmenopausal women.
    • Estradiol also plays a critical role in male sexual function being essential for modulating libido, erectile function, and spermatogenesis.
    • All estrogens act by binding to estrogen receptors in estrogen-responsive tissues. Estrogens work by a negative feedback mechanism to reduce circulating levels of gonadotrophins, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in postmenopausal women.
    • Estradiol belongs to the class of medicines called estrogens.

    2. Upsides

    • May be used for the treatment of moderate to severe vasomotor symptoms (eg, hot flashes/flushes), and vulvar and vaginal atrophy associated with menopause. However, topical estrogen products are preferred if the condition is vulvar or vaginal atrophy.
    • Treats low estrogen levels associated with hypogonadism, castration, or primary ovarian failure.
    • May be used in appropriate patients for the palliative care of breast cancer in women or men with metastatic disease.
    • May be used in the palliation of advanced androgen-dependent prostate cancer.
    • May be considered for the prevention of postmenopausal osteoporosis in women at significant risk and for whom non-estrogen treatments are not appropriate. However, the 2017 American College of Physicians (ACP) guidelines do not recommend its use for this indication.
    • Generic estradiol is available.

    3. Downsides

    If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include:

    • Bleeding changes, an increase in the incidence of vaginal candidiasis, breast pain and discharge, high blood pressure, nausea, vomiting, abdominal cramps, scalp hair loss, hirsutism, headache, mood disturbances, weight changes, fluid retention, skin changes, or an exacerbation of endometriosis. Estradiol may also exacerbate pre-existing conditions such as asthma, diabetes, epilepsy, and migraine and interfere with some laboratory tests.
    • Estrogens are associated with an increased risk of endometrial cancer. All women taking estradiol should be monitored and any persistent or recurrent abnormal vaginal bleeding should be investigated, and endometrial sampling undertaken when indicated.
    • An increased risk of heart attack (myocardial infarction), stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis have been associated with estrogen use (including estradiol), with or without progestins. An increased risk of dementia has also been reported in postmenopausal women 65 years of age or older.
    • Estrogens, with or without progestins should be prescribed at the lowest effective dose for the shortest possible time.
    • With regard to osteoporosis, estradiol has been shown to prevent vertebral bone loss in postmenopausal women. However, it does not restore bone mass to premenopausal levels, and once discontinued, bone loss reverts to what it was during the immediate postmenopausal period. The 2017 ACP guidelines for the treatment of osteoporosis do not recommend estrogen therapy for postmenopausal women with established osteoporosis.
    • Should not be used in women with undiagnosed abnormal genital bleeding, with a known or suspected history of breast cancer except in appropriate patients when used for palliation, with estrogen-dependent cancer, with active deep vein thrombosis, pulmonary embolism, or a history of these conditions. Estradiol is also not suitable for people with a recent history of stroke, a heart attack, other thromboembolic disease, liver disease, or known or suspected pregnancy.
    • Estrogen use is associated with a two to four-fold increased risk of gallbladder disease requiring surgery. It may also lead to severe high calcium levels in patients with breast cancer or bone metastases. Visual abnormalities have also been reported.
    • In women who have not had a hysterectomy, the addition of a progestin for 10 days each cycle lowers the risk of endometrial hyperplasia (which may be a precursor to endometrial cancer).
    • Blood pressure and cholesterol/triglyceride levels should be monitored regularly throughout estrogen therapy.
    • People with hypothyroidism receiving replacement therapy may require increased doses of thyroid replacement therapy when taking estrogens.

    Note: In general, seniors or children, people with certain medical conditions (such as liver or kidney problems, heart disease, diabetes, seizures) or people who take other medications are more at risk of developing a wider range of side effects. View complete list of side effects

    4. Bottom Line

    Estradiol is a synthetic form of estrogen that may be given for several different indications, including the relief of menopausal symptoms or low estrogen levels caused by other conditions. Its use is associated with an increased risk of endometrial and breast cancer and cardiovascular disease. The ACP no longer recommends estrogens for the treatment of postmenopausal osteoporosis.



    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 1
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 2
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 3
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 7


    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 9
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 10
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 11
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 12
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 13
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 14
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 15
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 16
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 17
    Shop High Quality Cheap Price Semaglutide CAS 910463-68-2 Lose Weight  Global Warehouse-Detailed Image 18

    Certificates

    Basic Info
    Product Name:

    Estradiol

    Other Name:

    Estra-1,3,5(10)-triene-3,17-diol (17β)-;Estradiol;(17β)-Estra-1,3,5(10)-triene-3,17-diol;Altrad;Bardiol;Beta-estradiol;Dihydrofollicular hormone;Dihydrofolliculin;Dihydromenformon;Dihydrotheelin;Dihydroxyestrin;Diogyn;Diogynets;3,17-Epidihydroxyestratriene;Estraldine;Dimenformon;Estrovite;Femestral;Femogen;Gynergon;Gynoestryl;Lamdiol;Macrodiol;Nordicol;Oestergon;Oestradiol;Oestroglandol;Ovahormon;Ovasterol;Ovastevol;Ovocyclin;Primofol;Profoliol;Progynon;Progynon DH;Syndiol;Theelin,dihydro-;Estra-1,3,5(10)-triene-3,17β-diol;Ginosedol;Estra-1,3,5(10)-triene-3,17-diol,(17β)-;β-Estradiol;(+)-3,17β-Estradiol;Oestra-1,3,5(10)-triene-3,17β-diol;3,17β-Dihydroxyestra-1,3,5(10)-triene;3,17β-Estradiol;Perlatanol;Aquadiol;Follicyclin;Corpagen;17β-Oestradiol;Estradiol-17β;Estrace;Compudose;Estraderm;Compudose 365;E 2;Compudose 200;Estrogel;Estraderm TTS;Oestrogel;Menorest;Systen;Evorel;Climaderm;13β-Methyl-1,3,5(10)-gonatriene-3,17β-ol;Estraderm TTS 50;Epiestriol 50;Estroclim 50;Dermestril;Climara;Oesclim;17β-Estradiol;Encore;Aerodiol;Divigel;Sandrena 1;Vagifem;Gelestra;Estraderm TTS 100;Zumenon;Vivelle;NSC 9895;Profoliol B;Ovocylin;Estring Vaginal Ring;Estroclim;Estradot;Femanest;Estrogel HBF;Absorlent Matrix;FemSeven;Estrapatch;Estraderm MX;Alora;Estasorb;Estredox;Estreva;Bio-E Gel;Benzogynestry;Estropause;Menostar;Evamist;Zesteem;Compudose 400;Compudose 100;Vivelle-Dot;Sprediol;Elestrim;873662-39-6;1050677-52-5;1206475-11-7

    CAS No.:

    50-28-2

    Molecular Formula:

    C18H24O2

    InChIKeys:

    InChIKey=VOXZDWNPVJITMN-ZBRFXRBCSA-N

    Molecular Weight:

    272.38200

    Exact Mass:

    272.38

    EC Number:

    200-023-8

    HScode:

    29372390

    Characteristics
    PSA:

    40.46000

    XLogP3:

    3.60920

    Appearance:

    Solid

    Density:

    1.17g/cm3

    Melting Point:

    173-179 °C

    Boiling Point:

    445.9ºC at 760mmHg

    Flash Point:

    209.6ºC

    Refractive Index:

    1.599

    Water Solubility:

    Soluble in dimethyl sulfoxide, ethanol , water, phosphate buffer saline, dimethyl formamide, acetone, dioxane and alkali hydroxides. Slightly soluble in vegetable oils.

    Storage Conditions:

    2-8ºC

    Vapor Pressure:

    6.38X10-9 mm Hg at 25 deg C (est)

    Toxicity:

    LD50 subcutaneous in rat: > 300mg/kg

    Specific rotation:

    Specific optical rotation at 25 °C for D (sodium) line: +76 deg at 25 °C/D to +83 deg at 25 °C/D (dioxane)

    Odor:

    Odorless

    PKA:

    10.46±0.03

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 1A

    Reproductive toxicity, Additional category for effects on or via lactation

    Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H351 Suspected of causing cancer

    H360 May damage fertility or the unborn child

    H362 May cause harm to breast-fed children

    H410 Very toxic to aquatic life with long lasting effects

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P260 Do not breathe dust/fume/gas/mist/vapours/spray.

    P263 Avoid contact during pregnancy and while nursing.

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    P273 Avoid release to the environment.

    Response

    P318 IF exposed or concerned, get medical advice.

    P391 Collect spillage.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Do not store unpouched. Apply immediately upon removal from the protective pouch.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptide,API,HCG,Amino Acids,Plant Extract,Vitamin

    Location:

    Room H0413, Building 1, No. 58, Guanggu Avenue, East Lake New Technology Development,Wuhan

    Year of Establishment:

    2020

  • Inquiry History
    35 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    oestrogen β-ESTRADIOL Estradiol 17β-Estradiol 17β-Oestradiol E2 98% Powder 50-28-2 Senwayer

    100 MG May 27, 2025
    United Kingdom

    Factory Wholesale Estradiol Raw Materials 99% Powder CAS 50-28-2 EGC-Estradiol

    3 KG Jan 4, 2024
    United States

    99% β-estradiol CAS NO 50-28-2

    20 G Sep 5, 2024
    Australia

    High Purity Beta-Estradiol Estrogen Drugs Estradiol Powder CAS 50-28-2

    100 G Nov 6, 2024
    Australia

    17 beta-estradiol powder (CAS 50-28-2

    10 G Sep 18, 2024
    Hungary

    High Purity Beta-Estradiol Estrogen Drugs Estradiol Powder CAS 50-28-2

    5 G Jun 29, 2026
    Hungary

    High Purity Beta-Estradiol Estrogen Drugs Estradiol Powder CAS 50-28-2

    12 G Dec 30, 2025
    Hungary

    large image1 oestrogen β-ESTRADIOL Estradiol 17β-Est E2 98% Powder 50-28-2

    12 G Dec 30, 2025
    France

    Hormones Estradiol CAS No 50-28-2 with High Purity Estrogen Drugs

    20000 MT Aug 31, 2023
    Switzerland

    Hormones Estradiol CAS No 50-28-2 with High Purity Estrogen Drugs

    10000 MT Aug 27, 2023
    United Kingdom

    99% High Purity CAS 50-28-2 Estradiol with Favorable Price 99% white powder Lingding-91 Lingding

    50 G Nov 10, 2023
    Japan

    Estradiol

    1 G Aug 6, 2024
    United States

    17-Beta Estradiol

    10 G Sep 24, 2024
    United Kingdom

    Beta-Estradiol

    10 G Apr 16, 2026
    Czech

    estradiol

    20 G Nov 23, 2025
    United Kingdom

    17b Estradiol

    50 G Oct 21, 2025
    Pakistan

    17beta-estradiol

    1 KG Sep 29, 2025
    Canada

    Estradiol

    1 KG Jun 18, 2025
    South Africa

    Estradiol 99% Purity Estradiol Raw Powder

    1 KG Dec 17, 2024
    United States

    Estradiol 99% White Powder

    5 G Nov 24, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.